Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Molecular and stimulus-response profiles illustrate heterogeneity between peripheral and cord blood-derived human mast cells

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Niels Borregaard, M.D. (1951-2017)

    Research output: Contribution to journalJournal articleCommunication

  2. Smoking reduces circulating CD26hiCD161hi MAIT cells in healthy individuals and patients with multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. CD4+/CD8+ double-positive T cells: more than just a developmental stage?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Candida albicans escapes from mouse neutrophils

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Circulating allergen-specific T2 lymphocytes: CCR4rather than CLAis the predominant phenotype in peanut-allergic subjects

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Clinical relevance of sensitization to hydrolyzed wheat protein in wheat-sensitized subjects

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Food allergy: setting the scene for tolerance induction

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Different protocols exist for in vitro development of HuMCs from hematopoietic stem cells, which results in distinct mast cells regarding molecular markers and activation patterns. Here, we introduce a SR profile using immunological, neurogenic, and pharmacological stimuli to characterize cellular functionality. Mast cells were obtained from three culture protocols using two types of PBdMCs (CD34(+) PBdMC or CD133(+) PBdMC) and one type of CBdMC (CD133(+) CBdMC). We analyzed resting cells for specific mast cell markers at protein and mRNA levels, thereby creating a molecular profile. To characterize the SR profile, we stimulated cells with anti-IgE, C3a, C5a, Substance P, or Compound 48/80 and measured the release of histamine and cytokines (IL-10, IL-13, GM-CSF, TNF-α). Molecular profiling revealed that CD133(+) CBdMC expressed less chymase, FcεRIα, and CD203c but more CD117 compared with CD34(+) and CD133(+) PBdMC. The SR profile for histamine release illustrated a functional heterogeneity between PBdMC and CBdMC. PBdMC released >10% histamine upon stimulation with anti-IgE, C3a, Substance P, and Compound 48/80, whereas CBdMC only reacted to C3a. Cytokine secretion was only detected after anti-IgE stimulation. Here, the SR profile identified the CD133(+) PBdMC as the most active cells regarding secretion of IL-10, IL-13, GM-CSF, and TNF-α. Cells from all three culture protocols, however, produced IL-10 spontaneously at comparable levels. We recommend validating mast cell cultures by means of molecular and SR profiles to characterize the mast cells and enhance consensus among studies.
Original languageEnglish
JournalJournal of Leukocyte Biology
Volume95
Issue number6
Pages (from-to)893-901
ISSN0741-5400
DOIs
Publication statusPublished - 3 Feb 2014

Bibliographical note

June 2014
Journal of Leukocyte Biology
vol. 95 no. 6 893-901

ID: 42845854